Last reviewed · How we verify
Cost-Free Pharmacotherapy Group — Competitive Intelligence Brief
marketed
Behavioral Health
Small molecule
Live · refreshed every 30 min
Target snapshot
Cost-Free Pharmacotherapy Group (Cost-Free Pharmacotherapy Group) — Ottawa Heart Institute Research Corporation. Cost-Free Pharmacotherapy Group is a behavioral intervention that helps patients manage their medication adherence.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cost-Free Pharmacotherapy Group TARGET | Cost-Free Pharmacotherapy Group | Ottawa Heart Institute Research Corporation | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cost-Free Pharmacotherapy Group CI watch — RSS
- Cost-Free Pharmacotherapy Group CI watch — Atom
- Cost-Free Pharmacotherapy Group CI watch — JSON
- Cost-Free Pharmacotherapy Group alone — RSS
Cite this brief
Drug Landscape (2026). Cost-Free Pharmacotherapy Group — Competitive Intelligence Brief. https://druglandscape.com/ci/cost-free-pharmacotherapy-group. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab